11-57597584-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The ENST00000619430.2(SERPING1):c.-161A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 30)
Consequence
SERPING1
ENST00000619430.2 5_prime_UTR
ENST00000619430.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.18
Genes affected
SERPING1 (HGNC:1228): (serpin family G member 1) This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-57597584-A-G is Pathogenic according to our data. Variant chr11-57597584-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 3242430.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-57597584-A-G is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPING1 | ENST00000619430.2 | c.-161A>G | 5_prime_UTR_variant | 1/7 | 1 | ENSP00000478572 | ||||
SERPING1 | ENST00000405496.5 | c.-23+53A>G | intron_variant | 4 | ENSP00000384561 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152014Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
1
AN:
152014
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152014Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74248
GnomAD4 genome
AF:
AC:
1
AN:
152014
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
74248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary angioedema type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | research | DNA-diagnostics Laboratory, Research Centre For Medical Genetics | Jun 15, 2024 | The c.-161A>G variant in SERPING1 was observed in Azerbaijanian autosomal recessive HAE family with 2 homozygous siblings. The same variant has previously been reported in Turkish autosomal recessive HAE family with 3 homozygous siblings (Büyüköztürk et all, 2009). The c.-161A>G variant was absent in 136 ethnically matched control chromosomes analyzed and was present at extremely low frequency in gnomAD v4.1.0 database (0.0002 in South Asian only). Affected members displayed a concordant complement profile with HAE-I, whereas heterozygous individuals had mild decrease of C1Inh activities within normal range. Additionally, in vitro functional studies indicate that C1INH mRNA levels in homozygous and heterozygous carriers are reduced (Büyüköztürk et all, 2009). According to our observation and the published information of Büyüköztürk et all, 2009, the c.-161A>G variant meets ACMG /ClinGen SVI guidance criteria to be classified as pathogenic: PS3, PP1_Str, PS4_Mod, PM2_Sup - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at